Need to Minimize Bias When Surveying Patient Attitudes to Stopping cml Treatment

Lucia A. Villemagne–Sanchez; David M. Ross; Penelope Schofield

doi:10.3747/co.21.2177

You are currently on the new version of our website. Access the old version .

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Letter

1 December 2014

Need to Minimize Bias When Surveying Patient Attitudes to Stopping cml Treatment

and

Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia

Hematology Directorate, SA Pathology School of Medicine, University of Adelaide

Flinders University, Adelaide, Australia

⁴

Medical Centre, Adelaide, Australia

Curr. Oncol.2014, 21(6), 801-802;https://doi.org/10.3747/co.21.2177

Version Notes

Order Reprints

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Sanford et al. reported results from an interviewassisted survey of chronic myeloid leukemia (CML) patients, which indicated that neither treatment compliance nor the occurrence of side effects significantly affected patient willingness to stop tyrosine kinase inhibitor treatment¹.[...]

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Systemic Treatment Safety Symposium 2014: Oral Chemotherapy

Response to “Need to Minimize Bias When Surveying Patient Attitudes to Stopping cml Treatment”